Boston Scientific Corp (BSX) 14.98 $BSX
Uptrend Call Working As Boston Scientific Stock Rises 16.3% (BSX)
Comtex SmarTrend(R) - Fri Feb 13, 4:49PM CST
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on October 24th, 2014 at $12.89. In approximately 4 months, Boston Scientific has returned 16.26% as of today's recent price of $14.98.
BSX: 14.98 (+0.24)
Boston Scientific To Participate In The RBC Capital Markets 2015 Global Healthcare Conference
PR Newswire - Fri Feb 13, 7:30AM CST
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the RBC Capital Markets 2015 Global Healthcare Conference on February 25 in New York City.
BSX: 14.98 (+0.24)
Insider Trading Alert - CRM, HYGS And BSX Traded By Insiders
at The Street - Wed Feb 11, 9:45AM CST
Stocks with insider trader activity include CRM, HYGS and BSX
BSX: 14.98 (+0.24), HYGS: 14.25 (-0.28), CRM: 62.85 (+1.59)
CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 4:40PM CST
With this agreement, CR Bard Inc. (BCR) intends to expand the reach of Lutonix DCB and allow more patients suffering from PAD to benefit from this innovative technology.
HYH: 44.50 (+0.52), BSX: 14.98 (+0.24), BCR: 175.38 (+0.50), BRLI: 34.63 (+0.06)
Global Laparoscopy Devices Industry Report 2015-2020
M2 - Tue Feb 10, 10:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/6g2txj/global) has announced the addition of the "Global Laparoscopy Devices Industry Report 2015" report to their offering. The Global Laparoscopy Devices Industry Report 2015 is a professional and in-depth study on the current state of the laparoscopy devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The laparoscopy devices market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Laparoscopy devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on eighteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The laparoscopy devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Laparoscopy Devices Industry Overview - Global Laparoscopy Devices Market Status Analysis - Major Regions Laparoscopy Devices Market Status Analysis - Major Countries Laparoscopy Devices Market Status and Analysis - Major Companies Laparoscopy Devices Market Status and Analysis - Laparoscopy Devices Industry Chain and Marketing Channels Analysis - Laparoscopy Devices Industry Segment Market Analysis - Laparoscopy Devices Industry Development Trend - Laparoscopy Devices New Project Investment Feasibility Analysis - Global Laparoscopy Devices Industry Research Conclusions Companies Mentioned - Boston Scientific - COOK MEDICAL - Covidien - Ethicon Endo-Surgery - Fujifilm - HAWK - KARL STORZ - Kangji - OLYMPUS - OPTCAL - PAJUNK - RICHARD WOLF - SHENDA - SHIKONGHOU - SMITH & NEPHEW - Stryker - Tonglu - Tonglu Yida For more information visit http://www.researchandmarkets.com/research/6g2txj/global
BSX: 14.98 (+0.24), SNN: 35.82 (-0.28)
Patient Monitoring Global Market 2015 - Forecast to 2020
M2 - Tue Feb 10, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/vvvf8m/patient) has announced the addition of the "Patient Monitoring Global Market - Forecast to 2020" report to their offering. The global patient monitoring devices market is expected to reach approximately $24 billion by 2019 growing at CAGR of around 8.0%. North America commands the largest share and is expected to register a healthy market share by 2019. APAC is going to be one of the prominent regions for this market in coming years driven by the increased purchasing power and rising population. Patient monitoring is essential part of care process together with administration of therapy. The main aim of monitoring is to make sure that proper care [or] therapy can be given in advance to the arrival of complications. Patient monitoring is essential to take care in emergency and operating rooms, intensive and critical care units and it is extremely useful for recovery rooms, respiration therapy, radiology, outpatient care, and gastroenterology department, Transport, Home and sleep screening applications. Patient monitoring play key role to reduce complications, risks, infections as well assist in providing for patient comfort. Patient monitoring devices market is mainly divided into following segments such as Hemodynamic, neurology, respiratory, Cardiology, fetal and neonatal, multi parameters, remote patient monitors, temperature and weight monitors. Some of the key players in this market are Abbott Laboratories (U.S.), GE Health care (U.K.), Johnson & Johnson, Inc. (U.S.), Covidien (Ireland), Mindray Medical (China), Philips Healthcare (Netherlands), Drager Medical GmbH (Germany), and Roche Diagnostics Limited (Switzerland). Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global Patient Monitoring System Market, By Device 5 Global Patient Monitoring System Market, By End-Users 6 Regional Market Analysis 7 Company Developments 8 Major Company Profiles - Abbott Laboratories - Boston Scientific Corpoartion - Covidien Plc - Ge Healthcare - Johnson & Johnson - Medtronic Inc. - Omron Healthcare, Inc. - Philips Healthcare - Roche Ltd. - St. Jude Medical, Inc. Visit http://www.researchandmarkets.com/research/vvvf8m/patient
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Global Angiography Devices (Angiography systems, Catheters, Guide-Wires, Balloons, Contrast Media, Accessories) Market 2014-2019
M2 - Tue Feb 10, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/66llkk/angiography) has announced the addition of the "Angiography Devices Market by Technology, Products, Application & End-Users - Global Forecast to 2019" report to their offering. The global angiography devices market is estimated to reach $27.7 billion in 2019, at a CAGR of 4.4% from 2014 to 2019 Angiography is a medical imaging procedure used to visualize blood vessels (arteries and veins) inside the body. Angiography devices are used to diagnose and evaluate many diseases of blood vessels and related conditions, such as injuries, aneurysms (ballooning of a blood vessel), blockages (due to blood clots or plaques), stenosis (narrowing of a blood vessel), congenital (birth-related) heart abnormalities, disorganized blood vessels, and blood supply to tumors. Images captured trough angiography is called as angiograms. The angiography devices market is mainly driven by technological advances, innovative product offerings, and growing aging population and increasing prevalence of vascular diseases. However, the lack of reimbursement for these systems and the presence of stringent regulations are expected to restrain the growth of this market in the forecast period. The angiography devices market in this report is broadly segmented by technology, products, applications, procedures, indications, and end users. The market, by products, is segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. The market by technology is segmented into X-ray, computed tomography, and magnetic resonance angiography. Based on applications the market is segmented as diagnostic and therapeutic. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Angiography Devices Market, By Technology 7 Angiography Devices Market, By Products 8 Angiography Devices Market, By Type Of Application 9 Angiography Devices Market, By Procedure 10 Angiography Devices Market, By Indication 11 Angiography Devices Market, By End-Users 12 Geography Analysis 13 Competitive Landscape 14 Company Profiles - Abbott Vascular - Boston Scientific Corporation - Cordis Corporation (A Jnj Company) - GE Healthcare - Medtronic Inc. - Philips Healthcare - ST. Jude Medical - Shimadzu Corporation - Siemens Healthcare - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/66...ngiography
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Watch for Boston Scientific to Potentially Rebound After Falling 1.90% Yesterday
Comtex SmarTrend(R) - Mon Feb 09, 5:00PM CST
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $14.39 to a high of $14.78. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $14.66 on volume of 9.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BSX: 14.98 (+0.24)
SmarTrend Watching for Potential Rebound in Shares of Boston Scientific After 1.90% Loss
Comtex SmarTrend(R) - Mon Feb 09, 5:00PM CST
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $14.39 to a high of $14.78. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $14.66 on volume of 9.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BSX: 14.98 (+0.24)
Boston Scientific To Participate In The Leerink 2015 Global Healthcare Conference
PR Newswire - Mon Feb 09, 4:22PM CST
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink 2015 Global Healthcare Conference on February 11 in New York City.
BSX: 14.98 (+0.24)
Boston Scientific signs up to distribute Bard DCB
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 10:46AM CST
BSX: 14.98 (+0.24), BCR: 175.38 (+0.50)
U.S. Gastrointestinal Endoscopic Devices Market 2014 - Executive Summary
M2 - Mon Feb 09, 9:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/jn38r5/u_s) has announced the addition of the "U.S. Gastrointestinal Endoscopic Devices Market (Executive Summary)" report to their offering. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). The infusion pump market is further divided into segments for large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. Main Markets Covered: - GI endoscopes - capsule endoscopy - virtual colonoscopy - stenting and dilation devices - ERCP devices - biopsy forceps - polypectomy snares - FNA devices - specimen and foreign body removal devices - hemostasis devices - anti-reflux devices - enteral feeding devices Procedures: - Colonoscopy Procedures - Sigmoidoscopy Procedures - Ultrasound Endoscopy Procedures - Capsule Endoscopy Procedures - Virtual Colonoscopy Procedures - Stenting and Dilation Procedures - Endoscopic Retrograde Cholangiopancreatography Procedures - Biopsy Forceps Procedures - Tumor and Polyp Removal Procedures - Specimen Retrieval Procedures - Foreign-Body Retrieval Procedures - Hemostasis Procedures - Anti-Reflux Procedures - Enteral Feeding Device Placements - Esophagus Ablation Procedures Companies Mentioned - Abbott Nutrition - Boston Scientific - C. R. Bard - ConMed Linvatec - Cook Medical - Covidien - ERBE - EndoGastric Solutions - Fujinon - GE Medical Systems - Given Imaging - Kimberly-Clark - Olympus - Pentax - US Endoscopy - Vital Images For more information visit http://www.researchandmarkets.com/research/jn38r5/u_s
BSX: 14.98 (+0.24), MDSY: 2.97 (+0.02)
Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon
PR Newswire - Mon Feb 09, 8:00AM CST
Boston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard"
today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB) in the United States under a limited distribution agreement reached with Bard. Terms of the agreement were not disclosed.
BSX: 14.98 (+0.24), BCR: 175.38 (+0.50)
Global Spinal Cord Stimulation (Rechargeable SCS System & Non-Rechargeable SCS System) Market Trends & Opportunities 2014-19
M2 - Mon Feb 09, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t3fksk/global_spinal) has announced the addition of the "Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)" report to their offering. The report Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019) provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). The report also assesses the main types of SCS devices - the rechargeable and non-rechargeable spinal cord stimulation devices. Further, key players of the industry like Boston Scientific Corporation, St. Jude Medical and Medtronic have been profiled and analyzed in the report. Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries. Acknowledging these factors, it could be said that the Spinal cord Stimulation market business will certainly gain importance in the years to come. Strict regulations, environment issues, dearth of expertise and trained healthcare workers and several other issues pose major challenge to the growth of this business. Major trends prevailing in the spinal cord stimulation market are advancement in spine surgery, changing surgeon preferences, mergers & acquisitions and incidence of pain conditions in the US households. Company Coverage - Boston Scientific - Nevro - St. Jude Medical - Medtronic Key Topics Covered: 1. Executive Summary 2. Spinal Cord Injuries and Stimulation: An Introduction 3. Global Spinal Cord Stimulation Market Analysis 4. Spinal Cord Stimulation Market: Segment Analysis 5. The US Spinal Cord Stimulation Market 6. Global Spinal Cord Stimulation Market dynamics 8. Competitive Landscape: Spinal Cord Stimulation Market 9. Company Profiles: Spinal Cord Stimulation Market For more information visit http://www.researchandmarkets.com/research/t3...bal_spinal
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Boston Scientific Up 17.6% Since SmarTrend Uptrend Call (BSX)
Comtex SmarTrend(R) - Fri Feb 06, 11:04AM CST
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on October 24th, 2014 at $12.89. In approximately 4 months, Boston Scientific has returned 17.62% as of today's recent price of $15.16.
BSX: 14.98 (+0.24)
U.S. Gastrointestinal Endoscopic Devices Market Report
M2 - Fri Feb 06, 8:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/5rf83x/u_s) has announced the addition of the "U.S. Gastrointestinal Endoscopic Devices Market " report to their offering. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). The infusion pump market is further divided into segments for large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. The total U.S. gastrointestinal (GI) endoscopic device market encompasses a wide range of product segments, including: GI endoscopes, capsule endoscopy, virtual colonoscopy, stenting and dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, fine aspiration needles, foreign body and specimen removal devices, hemostasis devices, anti-reflux devices, enteral feeding devices and Barrett's esophagus ablation devices. Market expansion over the forecast period will be driven by continuous growth in demand for GI screening and intervention procedures. The demand for colorectal cancer screening is expected to continue increasing over the forecast period. The most common procedure used to screen for colorectal cancer is a colonoscopy because of its efficiency and its ability to facilitate the diagnosis and treatment of colon cancer at the same time. However, recent positive publicity for virtual colonoscopy will drive that segment, likely at the expense of the conventional colonoscopy segment. Together, these two segments are expected to greatly increase colorectal cancer screening rates. Moreover, the increase in public awareness about the risks of colorectal cancer and the advantages of early treatment is leading more individuals to undergo screening. As the U.S. population ages, this trend will likely persist. This rising demand for colorectal cancer screening is driving the majority of the GI endoscopic market in the U.S., particularly the market for GI endoscopes and instrumentation. Technological advancements will continue to drive the U.S. market for gastrointestinal devices, most prevalently in the GI endoscope market. Doctors are constantly looking for products with proven results and companies that strive to create efficient devices. Manufacturers are working together with doctors to create new solutions and products, and doctors are constantly in contact with companies, suggesting new procedures and testing new devices. Technological developments also have a positive effect on the market by driving prices, leading to an increased overall market value. Companies Mentioned - Abbott Nutrition - Boston Scientific - C. R. Bard - ConMed Linvatec - Cook Medical - Covidien - ERBE - EndoGastric Solutions - Fujinon - GE Medical Systems - Given Imaging - Kimberly-Clark - Olympus - Pentax - US Endoscopy - Vital Images For more information visit http://www.researchandmarkets.com/research/5rf83x/u_s
BSX: 14.98 (+0.24), MDSY: 2.97 (+0.02)
Boston Scientific Overtakes Medtronic in Medical Device Market for Back Pain and Failed Back Surgery Syndrome
GlobeNewswire - Thu Feb 05, 10:00AM CST
via PRWEB - According to a new report published by iData Research, the spinal cord stimulator (SCS) market was valued at $1.3 billion in 2014. Favorable reimbursement, leading to increased application and significant investments in new technology development for the treatment of failed back surgery syndrome, has driven market growth in the last several years.
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
InfinityQS Clients Named 2014 IndustryWeek Best Plants Winners for Manufacturing Excellence
PR Newswire - Thu Feb 05, 7:43AM CST
InfinityQS International, Inc., the global authority on real-time quality and Manufacturing Intelligence, announces that two clients have been named 2014 IndustryWeek Best Plants winners - Boston Scientific's Maple Grove, Minn., plant and General Cable Corp.'s Marion, Ind., plant. Both locations use the InfinityQS ProFicient Enterprise Quality Hub to improve visibility, reduce variation, drive product quality and deliver manufacturing excellence.
BSX: 14.98 (+0.24), BGC: 14.40 (+0.51)
Global Electrophysiology Devices Industry Report 2015 - Forecasts to 2020
M2 - Thu Feb 05, 6:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/v7rdl9/global) has announced the addition of the "Global Electrophysiology Devices Industry Report 2015" report to their offering. The Global Electrophysiology Devices Industry Report 2015 is a professional and in-depth study on the current state of the electrophysiology devices Industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The electrophysiology devices market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Electrophysiology devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on thirteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The electrophysiology devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Electrophysiology Devices Industry Overview - Electrophysiology Devices International and China Market Analysis - Electrophysiology Devices Technical Data and Manufacturing Plants Analysis - Electrophysiology Devices Production by Regions by Technology by Applications - Electrophysiology Devices Manufacturing Process and Cost Structure - Electrophysiology Devices Productions Supply Sales Demand Market Status and Forecast 2009-2014 - Electrophysiology Devices Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Electrophysiology Devices Marketing Channels Analysis - Electrophysiology Devices Industry Development Trend - Electrophysiology Devices Industry Development Proposals - Electrophysiology Devices New Project Investment Feasibility Analysis - Global and China Electrophysiology Devices Industry Research Conclusions Companies Mentioned - Biotronik - Boston Scientific - GE Healthcare - HTONG - Huanan Medical - JJET - Johnson & Johnson - Medtronic Inc - Micro Port - Natus - Nihon Kohden - Philips Healthcare - St. Jude Medical,Inc. For more information visit http://www.researchandmarkets.com/research/v7rdl9/global
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Uptrend Call Working As Boston Scientific Stock Rises 16.3% (BSX)
Comtex SmarTrend(R) - Fri Feb 13, 4:49PM CST
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on October 24th, 2014 at $12.89. In approximately 4 months, Boston Scientific has returned 16.26% as of today's recent price of $14.98.
BSX: 14.98 (+0.24)
Boston Scientific To Participate In The RBC Capital Markets 2015 Global Healthcare Conference
PR Newswire - Fri Feb 13, 7:30AM CST
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the RBC Capital Markets 2015 Global Healthcare Conference on February 25 in New York City.
BSX: 14.98 (+0.24)
Insider Trading Alert - CRM, HYGS And BSX Traded By Insiders
at The Street - Wed Feb 11, 9:45AM CST
Stocks with insider trader activity include CRM, HYGS and BSX
BSX: 14.98 (+0.24), HYGS: 14.25 (-0.28), CRM: 62.85 (+1.59)
CR Bard, Boston Scientific Ink Lutonix Distribution Agreement - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 4:40PM CST
With this agreement, CR Bard Inc. (BCR) intends to expand the reach of Lutonix DCB and allow more patients suffering from PAD to benefit from this innovative technology.
HYH: 44.50 (+0.52), BSX: 14.98 (+0.24), BCR: 175.38 (+0.50), BRLI: 34.63 (+0.06)
Global Laparoscopy Devices Industry Report 2015-2020
M2 - Tue Feb 10, 10:19AM CST
Research and Markets (http://www.researchandmarkets.com/research/6g2txj/global) has announced the addition of the "Global Laparoscopy Devices Industry Report 2015" report to their offering. The Global Laparoscopy Devices Industry Report 2015 is a professional and in-depth study on the current state of the laparoscopy devices industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The laparoscopy devices market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Laparoscopy devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on eighteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The laparoscopy devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Laparoscopy Devices Industry Overview - Global Laparoscopy Devices Market Status Analysis - Major Regions Laparoscopy Devices Market Status Analysis - Major Countries Laparoscopy Devices Market Status and Analysis - Major Companies Laparoscopy Devices Market Status and Analysis - Laparoscopy Devices Industry Chain and Marketing Channels Analysis - Laparoscopy Devices Industry Segment Market Analysis - Laparoscopy Devices Industry Development Trend - Laparoscopy Devices New Project Investment Feasibility Analysis - Global Laparoscopy Devices Industry Research Conclusions Companies Mentioned - Boston Scientific - COOK MEDICAL - Covidien - Ethicon Endo-Surgery - Fujifilm - HAWK - KARL STORZ - Kangji - OLYMPUS - OPTCAL - PAJUNK - RICHARD WOLF - SHENDA - SHIKONGHOU - SMITH & NEPHEW - Stryker - Tonglu - Tonglu Yida For more information visit http://www.researchandmarkets.com/research/6g2txj/global
BSX: 14.98 (+0.24), SNN: 35.82 (-0.28)
Patient Monitoring Global Market 2015 - Forecast to 2020
M2 - Tue Feb 10, 8:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/vvvf8m/patient) has announced the addition of the "Patient Monitoring Global Market - Forecast to 2020" report to their offering. The global patient monitoring devices market is expected to reach approximately $24 billion by 2019 growing at CAGR of around 8.0%. North America commands the largest share and is expected to register a healthy market share by 2019. APAC is going to be one of the prominent regions for this market in coming years driven by the increased purchasing power and rising population. Patient monitoring is essential part of care process together with administration of therapy. The main aim of monitoring is to make sure that proper care [or] therapy can be given in advance to the arrival of complications. Patient monitoring is essential to take care in emergency and operating rooms, intensive and critical care units and it is extremely useful for recovery rooms, respiration therapy, radiology, outpatient care, and gastroenterology department, Transport, Home and sleep screening applications. Patient monitoring play key role to reduce complications, risks, infections as well assist in providing for patient comfort. Patient monitoring devices market is mainly divided into following segments such as Hemodynamic, neurology, respiratory, Cardiology, fetal and neonatal, multi parameters, remote patient monitors, temperature and weight monitors. Some of the key players in this market are Abbott Laboratories (U.S.), GE Health care (U.K.), Johnson & Johnson, Inc. (U.S.), Covidien (Ireland), Mindray Medical (China), Philips Healthcare (Netherlands), Drager Medical GmbH (Germany), and Roche Diagnostics Limited (Switzerland). Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Analysis 4 Global Patient Monitoring System Market, By Device 5 Global Patient Monitoring System Market, By End-Users 6 Regional Market Analysis 7 Company Developments 8 Major Company Profiles - Abbott Laboratories - Boston Scientific Corpoartion - Covidien Plc - Ge Healthcare - Johnson & Johnson - Medtronic Inc. - Omron Healthcare, Inc. - Philips Healthcare - Roche Ltd. - St. Jude Medical, Inc. Visit http://www.researchandmarkets.com/research/vvvf8m/patient
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), ABT: 46.09 (+0.87), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Global Angiography Devices (Angiography systems, Catheters, Guide-Wires, Balloons, Contrast Media, Accessories) Market 2014-2019
M2 - Tue Feb 10, 5:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/66llkk/angiography) has announced the addition of the "Angiography Devices Market by Technology, Products, Application & End-Users - Global Forecast to 2019" report to their offering. The global angiography devices market is estimated to reach $27.7 billion in 2019, at a CAGR of 4.4% from 2014 to 2019 Angiography is a medical imaging procedure used to visualize blood vessels (arteries and veins) inside the body. Angiography devices are used to diagnose and evaluate many diseases of blood vessels and related conditions, such as injuries, aneurysms (ballooning of a blood vessel), blockages (due to blood clots or plaques), stenosis (narrowing of a blood vessel), congenital (birth-related) heart abnormalities, disorganized blood vessels, and blood supply to tumors. Images captured trough angiography is called as angiograms. The angiography devices market is mainly driven by technological advances, innovative product offerings, and growing aging population and increasing prevalence of vascular diseases. However, the lack of reimbursement for these systems and the presence of stringent regulations are expected to restrain the growth of this market in the forecast period. The angiography devices market in this report is broadly segmented by technology, products, applications, procedures, indications, and end users. The market, by products, is segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories. The market by technology is segmented into X-ray, computed tomography, and magnetic resonance angiography. Based on applications the market is segmented as diagnostic and therapeutic. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Angiography Devices Market, By Technology 7 Angiography Devices Market, By Products 8 Angiography Devices Market, By Type Of Application 9 Angiography Devices Market, By Procedure 10 Angiography Devices Market, By Indication 11 Angiography Devices Market, By End-Users 12 Geography Analysis 13 Competitive Landscape 14 Company Profiles - Abbott Vascular - Boston Scientific Corporation - Cordis Corporation (A Jnj Company) - GE Healthcare - Medtronic Inc. - Philips Healthcare - ST. Jude Medical - Shimadzu Corporation - Siemens Healthcare - Toshiba Corporation For more information visit http://www.researchandmarkets.com/research/66...ngiography
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Watch for Boston Scientific to Potentially Rebound After Falling 1.90% Yesterday
Comtex SmarTrend(R) - Mon Feb 09, 5:00PM CST
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $14.39 to a high of $14.78. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $14.66 on volume of 9.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BSX: 14.98 (+0.24)
SmarTrend Watching for Potential Rebound in Shares of Boston Scientific After 1.90% Loss
Comtex SmarTrend(R) - Mon Feb 09, 5:00PM CST
Boston Scientific (NYSE:BSX) traded in a range yesterday that spanned from a low of $14.39 to a high of $14.78. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $14.66 on volume of 9.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BSX: 14.98 (+0.24)
Boston Scientific To Participate In The Leerink 2015 Global Healthcare Conference
PR Newswire - Mon Feb 09, 4:22PM CST
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink 2015 Global Healthcare Conference on February 11 in New York City.
BSX: 14.98 (+0.24)
Boston Scientific signs up to distribute Bard DCB
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 10:46AM CST
BSX: 14.98 (+0.24), BCR: 175.38 (+0.50)
U.S. Gastrointestinal Endoscopic Devices Market 2014 - Executive Summary
M2 - Mon Feb 09, 9:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/jn38r5/u_s) has announced the addition of the "U.S. Gastrointestinal Endoscopic Devices Market (Executive Summary)" report to their offering. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). The infusion pump market is further divided into segments for large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. Main Markets Covered: - GI endoscopes - capsule endoscopy - virtual colonoscopy - stenting and dilation devices - ERCP devices - biopsy forceps - polypectomy snares - FNA devices - specimen and foreign body removal devices - hemostasis devices - anti-reflux devices - enteral feeding devices Procedures: - Colonoscopy Procedures - Sigmoidoscopy Procedures - Ultrasound Endoscopy Procedures - Capsule Endoscopy Procedures - Virtual Colonoscopy Procedures - Stenting and Dilation Procedures - Endoscopic Retrograde Cholangiopancreatography Procedures - Biopsy Forceps Procedures - Tumor and Polyp Removal Procedures - Specimen Retrieval Procedures - Foreign-Body Retrieval Procedures - Hemostasis Procedures - Anti-Reflux Procedures - Enteral Feeding Device Placements - Esophagus Ablation Procedures Companies Mentioned - Abbott Nutrition - Boston Scientific - C. R. Bard - ConMed Linvatec - Cook Medical - Covidien - ERBE - EndoGastric Solutions - Fujinon - GE Medical Systems - Given Imaging - Kimberly-Clark - Olympus - Pentax - US Endoscopy - Vital Images For more information visit http://www.researchandmarkets.com/research/jn38r5/u_s
BSX: 14.98 (+0.24), MDSY: 2.97 (+0.02)
Boston Scientific And C. R. Bard Announce Distribution Agreement For Lutonix® Drug Coated Balloon
PR Newswire - Mon Feb 09, 8:00AM CST
Boston Scientific Corporation (NYSE: BSX) and C. R. Bard, Inc. (NYSE: BCR) ("Bard"
today announced that Boston Scientific will distribute the Lutonix® 035 Drug Coated Balloon Percutaneous Transluminal Angioplasty Catheter (Lutonix DCB) in the United States under a limited distribution agreement reached with Bard. Terms of the agreement were not disclosed. BSX: 14.98 (+0.24), BCR: 175.38 (+0.50)
Global Spinal Cord Stimulation (Rechargeable SCS System & Non-Rechargeable SCS System) Market Trends & Opportunities 2014-19
M2 - Mon Feb 09, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/t3fksk/global_spinal) has announced the addition of the "Global Spinal Cord Stimulation Market: Trends & Opportunities (2014-19)" report to their offering. The report Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019) provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-19). The report also assesses the main types of SCS devices - the rechargeable and non-rechargeable spinal cord stimulation devices. Further, key players of the industry like Boston Scientific Corporation, St. Jude Medical and Medtronic have been profiled and analyzed in the report. Spinal cord stimulation (SCS) is a pain relief technique that delivers a low-voltage electrical current continuously to the spinal cord to block the sensation of pain. SCS is the most commonly used implantable neuro-stimulation technology for management of pain syndromes. The growth of the global Spinal cord Stimulation market is driven by a number of factors that include rise in ageing demographics, rising healthcare expenditure per capita, growing cases of obesity and increasing number of failed surgeries. Acknowledging these factors, it could be said that the Spinal cord Stimulation market business will certainly gain importance in the years to come. Strict regulations, environment issues, dearth of expertise and trained healthcare workers and several other issues pose major challenge to the growth of this business. Major trends prevailing in the spinal cord stimulation market are advancement in spine surgery, changing surgeon preferences, mergers & acquisitions and incidence of pain conditions in the US households. Company Coverage - Boston Scientific - Nevro - St. Jude Medical - Medtronic Key Topics Covered: 1. Executive Summary 2. Spinal Cord Injuries and Stimulation: An Introduction 3. Global Spinal Cord Stimulation Market Analysis 4. Spinal Cord Stimulation Market: Segment Analysis 5. The US Spinal Cord Stimulation Market 6. Global Spinal Cord Stimulation Market dynamics 8. Competitive Landscape: Spinal Cord Stimulation Market 9. Company Profiles: Spinal Cord Stimulation Market For more information visit http://www.researchandmarkets.com/research/t3...bal_spinal
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
Boston Scientific Up 17.6% Since SmarTrend Uptrend Call (BSX)
Comtex SmarTrend(R) - Fri Feb 06, 11:04AM CST
SmarTrend identified an Uptrend for Boston Scientific (NYSE:BSX) on October 24th, 2014 at $12.89. In approximately 4 months, Boston Scientific has returned 17.62% as of today's recent price of $15.16.
BSX: 14.98 (+0.24)
U.S. Gastrointestinal Endoscopic Devices Market Report
M2 - Fri Feb 06, 8:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/5rf83x/u_s) has announced the addition of the "U.S. Gastrointestinal Endoscopic Devices Market " report to their offering. This market includes infusion pumps, intravenous (IV) sets, and needleless connectors (NLCs). The infusion pump market is further divided into segments for large volume, syringe, patient-controlled analgesia (PCA), electronic ambulatory and disposable ambulatory infusion pumps. The total U.S. gastrointestinal (GI) endoscopic device market encompasses a wide range of product segments, including: GI endoscopes, capsule endoscopy, virtual colonoscopy, stenting and dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, fine aspiration needles, foreign body and specimen removal devices, hemostasis devices, anti-reflux devices, enteral feeding devices and Barrett's esophagus ablation devices. Market expansion over the forecast period will be driven by continuous growth in demand for GI screening and intervention procedures. The demand for colorectal cancer screening is expected to continue increasing over the forecast period. The most common procedure used to screen for colorectal cancer is a colonoscopy because of its efficiency and its ability to facilitate the diagnosis and treatment of colon cancer at the same time. However, recent positive publicity for virtual colonoscopy will drive that segment, likely at the expense of the conventional colonoscopy segment. Together, these two segments are expected to greatly increase colorectal cancer screening rates. Moreover, the increase in public awareness about the risks of colorectal cancer and the advantages of early treatment is leading more individuals to undergo screening. As the U.S. population ages, this trend will likely persist. This rising demand for colorectal cancer screening is driving the majority of the GI endoscopic market in the U.S., particularly the market for GI endoscopes and instrumentation. Technological advancements will continue to drive the U.S. market for gastrointestinal devices, most prevalently in the GI endoscope market. Doctors are constantly looking for products with proven results and companies that strive to create efficient devices. Manufacturers are working together with doctors to create new solutions and products, and doctors are constantly in contact with companies, suggesting new procedures and testing new devices. Technological developments also have a positive effect on the market by driving prices, leading to an increased overall market value. Companies Mentioned - Abbott Nutrition - Boston Scientific - C. R. Bard - ConMed Linvatec - Cook Medical - Covidien - ERBE - EndoGastric Solutions - Fujinon - GE Medical Systems - Given Imaging - Kimberly-Clark - Olympus - Pentax - US Endoscopy - Vital Images For more information visit http://www.researchandmarkets.com/research/5rf83x/u_s
BSX: 14.98 (+0.24), MDSY: 2.97 (+0.02)
Boston Scientific Overtakes Medtronic in Medical Device Market for Back Pain and Failed Back Surgery Syndrome
GlobeNewswire - Thu Feb 05, 10:00AM CST
via PRWEB - According to a new report published by iData Research, the spinal cord stimulator (SCS) market was valued at $1.3 billion in 2014. Favorable reimbursement, leading to increased application and significant investments in new technology development for the treatment of failed back surgery syndrome, has driven market growth in the last several years.
BSX: 14.98 (+0.24), MDT: 75.26 (+0.33)
InfinityQS Clients Named 2014 IndustryWeek Best Plants Winners for Manufacturing Excellence
PR Newswire - Thu Feb 05, 7:43AM CST
InfinityQS International, Inc., the global authority on real-time quality and Manufacturing Intelligence, announces that two clients have been named 2014 IndustryWeek Best Plants winners - Boston Scientific's Maple Grove, Minn., plant and General Cable Corp.'s Marion, Ind., plant. Both locations use the InfinityQS ProFicient Enterprise Quality Hub to improve visibility, reduce variation, drive product quality and deliver manufacturing excellence.
BSX: 14.98 (+0.24), BGC: 14.40 (+0.51)
Global Electrophysiology Devices Industry Report 2015 - Forecasts to 2020
M2 - Thu Feb 05, 6:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/v7rdl9/global) has announced the addition of the "Global Electrophysiology Devices Industry Report 2015" report to their offering. The Global Electrophysiology Devices Industry Report 2015 is a professional and in-depth study on the current state of the electrophysiology devices Industry with a focus on the Chinese situation. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The electrophysiology devices market analysis is provided for both the international and Chinese domestic situations including development trends, competitive landscape analysis, key regions development status and a comparison analysis between the international and Chinese markets. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Electrophysiology devices industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on thirteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The electrophysiology devices industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Electrophysiology Devices Industry Overview - Electrophysiology Devices International and China Market Analysis - Electrophysiology Devices Technical Data and Manufacturing Plants Analysis - Electrophysiology Devices Production by Regions by Technology by Applications - Electrophysiology Devices Manufacturing Process and Cost Structure - Electrophysiology Devices Productions Supply Sales Demand Market Status and Forecast 2009-2014 - Electrophysiology Devices Key Manufacturers Analysis - Up and Down Stream Industry Analysis - Electrophysiology Devices Marketing Channels Analysis - Electrophysiology Devices Industry Development Trend - Electrophysiology Devices Industry Development Proposals - Electrophysiology Devices New Project Investment Feasibility Analysis - Global and China Electrophysiology Devices Industry Research Conclusions Companies Mentioned - Biotronik - Boston Scientific - GE Healthcare - HTONG - Huanan Medical - JJET - Johnson & Johnson - Medtronic Inc - Micro Port - Natus - Nihon Kohden - Philips Healthcare - St. Jude Medical,Inc. For more information visit http://www.researchandmarkets.com/research/v7rdl9/global
BSX: 14.98 (+0.24), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), STJ: 67.48 (+0.65)
